FDA Approves NDA017421 for DIAL Topical Solution Containing 0.25% Hexachlorophene

The U.S. Food and Drug Administration (FDA) has issued an approval for application NDA017421 submitted by DIAL. The approved product is a topical solution marketed under the brand name DIAL, containing 0.25% hexachlorophene. The submission was an original (ORIG) type, classified as Type 5 – New Formulation or New Manufacturer, with a standard review priority. The submission status date is March 10 1976, and the product’s marketing status is listed as discontinued. No reference drug or reference standard was cited for this product.